Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-25T19:25:27.118Z Has data issue: false hasContentIssue false
  • English
  • Français

Management and clinical outcome of sinonasal teratocarcinosarcoma: single institution experience

Published online by Cambridge University Press:  16 February 2010

A Budrukkar ,
J P Agarwal ,
S Kane ,
M Siddha ,
S Ghosh Laskar ,
P Pai ,
V Murthy ,
M Sengar  and
A D'Cruz
A Budrukkar*
Affiliation:
Department of Radiation Oncology, Tata Memorial Hospital, Parel, Mumbai, India
J P Agarwal
Affiliation:
Department of Radiation Oncology, Tata Memorial Hospital, Parel, Mumbai, India
S Kane
Affiliation:
Department of Pathology, Tata Memorial Hospital, Parel, Mumbai, India
M Siddha
Affiliation:
Department of Radiation Oncology, Tata Memorial Hospital, Parel, Mumbai, India
S Ghosh Laskar
Affiliation:
Department of Radiation Oncology, Tata Memorial Hospital, Parel, Mumbai, India
P Pai
Affiliation:
Department of Surgical Oncology, Tata Memorial Hospital, Parel, Mumbai, India
V Murthy
Affiliation:
Department of Radiation Oncology, Tata Memorial Hospital, Parel, Mumbai, India
M Sengar
Affiliation:
Department of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai, India
A D'Cruz
Affiliation:
Department of Surgical Oncology, Tata Memorial Hospital, Parel, Mumbai, India
*
Address for correspondence: Dr Ashwini Budrukkar, Assistant Professor, Department of Radiation Oncology, Tata Memorial Hospital, Ernest Borges Marg, Parel, Mumbai 400 012, India. Fax: +91 22 24146937 E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Purpose:

To study the outcome of patients with sinonasal teratocarcinosarcoma treated at a single institution.

Methods:

We reviewed the medical records of 22 patients with histopathologically proven sinonasal teratocarcinosarcoma diagnosed during the period 1993–2007. Treatment was completed in 16 patients.

Results:

Fourteen patients underwent surgery (six received craniofacial resection, four open surgery and four endoscopic resection); this was followed by radiation therapy with or without chemotherapy in 11 patients. Two patients received chemoradiation as the definitive treatment. At median follow up in surviving patients of 34 months (range one to 180 months), only five were controlled. Disease recurred in 11 patients, with a median time to recurrence of seven months. The two-year disease-free survival rate and the overall survival rate were 28 and 46 per cent, respectively.

Conclusion:

Sinonasal teratocarcinosarcoma appears to be an aggressive disease, with the majority of patients suffering locoregional failure. Multimodality treatment, in the form of a combination of surgery, radiation therapy and chemotherapy, appears to be the optimal approach.

Keywords

Paranasal Sinus NeoplasmsTeratocarcinosarcomaRadiationSurgery
Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 124 , Issue 7 , July 2010 , pp. 739 - 743
Copyright
Copyright © JLO (1984) Limited 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Heffner, DK, Hyams, VJ. Teratocarcinosarcoma (malignant teratoma?) of the nasal cavity and paranasal sinuses. Cancer 1984;47:2140–543.0.CO;2-Y>CrossRefGoogle Scholar
2Pai, SA, Naresh, KN, Masih, K, Ramarao, C, Borges, AM. Teratocarcinosarcoma of the paranasal sinus: a clinicopathologic and immunohistochemical study. Hum Pathol 1998;29:718–22CrossRefGoogle ScholarPubMed
3Carrizo, F, Pineda-Daboin, K, Neto, AG, Luna, MA. Pharyngeal teratocarcinosarcoma: review of the literature and report of two cases. Annals of Diagnostic Pathology 2006;10:339–42CrossRefGoogle ScholarPubMed
4Smith, SL, Hessel, AC, Luna, MA, Malpica, A, Rosenthal, DI, El-Naggar, AK. Sinonasal teratocarcinosarcoma of the head and neck. Arch Otolaryngol Head Neck Surg 2008;134:592–5CrossRefGoogle ScholarPubMed
5Fernanadez, PL, Cardesa, A, Alos, L, Pinto, J, Traserra, J. Sinonasal teratocarcinosarcoma: an unusual neoplasm. Pathol Res Pract 1995;191:166–71CrossRefGoogle Scholar
6Sharma, HS, Abdullah, JM, Othman, NH, Muhermad, M. Pathology in focus of teratocarcinosarcoma of the nasal cavity and ethmoid. J Laryngol Otol 1998;112:682–6CrossRefGoogle Scholar
7Abt, AB, Toker, C. Malignant teratoma of the paranasal sinuses. Archives of Pathology 1970;90:176–80Google ScholarPubMed
8Devgan, BK, Devgan, M, Gross, CW. Teratocarcinoma of the ethmoid sinus: review of literature plus a new case report. Otolaryngology 1978;86:689–95CrossRefGoogle Scholar
9Patchefsky, A, Sundmaker, W, Marden, PA. Malignant teratoma of ethmoid sinus. Cancer 1968;21:714–213.0.CO;2-J>CrossRefGoogle ScholarPubMed
10Shanmugaratnam, K, Kunaratnam, N, Chia, KB, Chiang, GSC, Sinniali, R. Teratoid carcinosarcoma of the paranasal sinuses. Pathology 1983;15:413–19CrossRefGoogle ScholarPubMed
11Meinelho, R, Bauer, F, Skouras, J, Moth, F. Blastomatous tumors of the respiratory tract. Cancer 1976;38:818–23Google Scholar
12Prasad, KC, Pai, RR, Padmanabhan, K, Chawla, S. Teratocarcinosarcoma of the nose, paranasal sinuses and nasopharynx. J Laryngol Otol 2003;117:321–4CrossRefGoogle ScholarPubMed
13Nitsche, M, Hermanna, RM, Christiansena, H, Bergerb, J, Pradiera, O. Rationale for individualized therapy in sinonasal teratocarcinosarcoma (SNTC): case report. Onkologie 2005;28:653–6Google ScholarPubMed